英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
Cannabigerol
|
25654-31-3 |
大麻萜酚
|
大麻萜酚;(E)-2-(3,7-二甲基-2,6-辛二烯基)-5-戊基间苯二酚
|
C21H32O2 |
316.47758 | |
ESI-09
|
263707-16-0 |
ESI-09
|
ALPHA-[(3-氯苯基)亚肼基]-5-(叔丁基)-BETA-氧代-3-异恶唑丙腈
|
C16H15ClN4O2 |
330.7689 | |
PI-103 Hydrochloride
|
371935-79-4 |
PI-103, HYDROCHLORIDE SALT, >99%
|
3-[4-(4-吗啉基)吡啶并[3',2':4,5]呋喃并[3,2-D]嘧啶-2-基]苯酚单盐酸盐;PI 103 HYDROCHLORIDE;PI103 HYDROCHLORIDE
|
C19H17ClN4O3 |
384.81628 | |
VUF 10166
|
155584-74-0 |
VUF 10166
|
2-Chloro-3-(4-Methyl-1-piperazinyl)quinoxaline;VUF 10166;2-chloro-3-(4-methylpiperazin-1-yl)quinoxaline;Quinoxaline, 2-chloro-3-(4-methyl-1-piperazinyl)-
|
C13H15N4Cl |
262.738 | |
CPPHA
|
693288-97-0 |
N-[4-氯-2-[(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)甲基]苯基]-2-羟基苯甲酰胺
|
N-[4-氯-2-[(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)甲基]苯基]-2-羟基苯甲酰胺
|
C22H15ClN2O4 |
406.8185 | |
HTH-01-015
|
1613724-42-7 |
N/A
|
5,13-二氢-4,13-三甲基-2-[[1-(4-哌啶基)-1H-吡唑-4-基]氨基]-6H-萘并[2,3-E]嘧啶并[5,4-B][1,4]二氮杂卓-6-酮;CS-2296
|
C26H28N8O |
468.55352 | |
HBX 41108
|
924296-39-9 |
7-氯-9-氧代-9H-茚并[1,2-B]吡嗪-2,3-二甲腈
|
7-氯-9-氧代-9H-茚并[1,2-B]吡嗪-2,3-二甲腈;CS-1900;HBX 41108;HBX-41108
|
C13H3N4OCl |
266.64212 | |
AIM-100
|
873305-35-2 |
5,6-二苯基-N-[[(2S)-四氢-2-呋喃基]甲基]呋喃并[2,3-D]嘧啶-4-胺
|
AIM-100;5,6-Diphenyl-N-[[(2S)-tetrahydro-2-furanyl]methyl]furo[2,3-d]pyrimidin-4-amine
|
C23H21N3O2 |
371.43174 | |
GSK2801
|
1619994-68-1 |
GSK2801
|
1-[1-[2-(甲基磺酰基)苯基]-7-丙氧基-3-吲哚嗪基]乙酮;GSK2801>98%;GSK2801;GSK-2801;GSK 2801;CS-1607;GSK-2801;GSK 280
|
C20H21NO4S |
371.45004 | |
Piclamilast
|
144035-83-6 |
吡拉米司特
|
|
C18H18N2O3Cl2 |
381.25312 | |
AZ-20
|
1233339-22-4 |
AZ20
|
AZ-20;AZ 20;CS-1335;4-[4-[(3R)-3-甲基-4-吗啉基]-6-[1-(甲基磺酰基)环丙基]-2-嘧啶基]-1H-吲哚
|
C21H24N4O3S |
412.50526 | |
VPC 23019
|
449173-19-7 |
VPC 23019
|
VPC 23019;(2R)-2-氨基-N-(3-辛基苯基)-3-(磷酰氧基)-丙酰胺;(R)-PHOSPHORIC ACID MONO-[2-AMINO-2-(3-OCTYL-PHENYLCARBAMOYL)-ETHYL] ESTER;VPC 23019
|
C17H29N2O5P |
372.396321 | |
2-Acetylfuro-1,4-naphthoquinone
|
83280-65-3 |
2-乙酰基呋喃并-1,4-萘醌
|
BBI608(那布卡辛);2-乙酰基呋喃并-1,4-萘醌;那布卡辛;2-乙酰基呋喃并-1,4-萘醌 5G;那帕卡辛;2-乙酰基萘并[2,3-B]呋喃-4,9-二酮;BBI-606;CS-945
|
C14H8O4 |
240.21092 | |
JZL195
|
1210004-12-8 |
JZL-195
|
JZL-195;JZL 195;JZL195;CS-1586
|
C24H23N3O5 |
433.45652 | |
WIKI4
|
838818-26-1 |
N/A
|
2-[3-[[4-(4-甲氧基苯基)-5-(4-吡啶基)-4H-1,2,4-三唑-3-基]硫基]丙基]-1H-苯并[DE]异喹啉-1,3(2H)-二酮
|
C29H23N5O3S |
521.6 | |
3-deazaneplanocin A Hydrochloride
|
120964-45-6 |
3-DEAZANEPLANOCIN A HYDROCHLORIDE
|
DZNEP;NSC 617989;(1S,2R,5R)-5-(4-氨基-1H-咪唑并[4,5-C]吡啶-1-基)-3-(羟基甲基)-3-环戊烯-1,2-二醇盐酸盐;DZNEP HYDROCHLORIDE;NSC 617989 HYDROCHLORIDE;3-DEAZANEPLANOCIN HYDROCHLORIDE;3-去氮腺嘌呤A
|
C12H14N4O3.HCl |
298.7255 | |
Risperidone-d4
|
1020719-76-9 |
利培酮D4
|
利培酮D4;3-[2-[4-(6-氟-1,2-苯并异恶唑-3-基)-1-哌啶基]乙基-1,1,2,2-D4]-6,7,8,9-四氢-2-甲基-4H-吡啶并[1,2-A]嘧啶-4-酮
|
C23H27N4O2F |
410.48448 | 696-055-9 |
PF-06447475
|
1527473-33-1 |
PF-06447475
|
PF-06447475>98%;CS-1734;PF 06447475;PF06447475;3-[4-(4-吗啉基)-7H-吡咯并[2,3-D]嘧啶-5-基]苯甲腈
|
C17H15N5O |
305.34 | |
DBeq
|
177355-84-9 |
DBEQ
|
CS-982;N2,N4-二苄基喹唑啉-2,4-二胺;JRF 12;JRF12;JRF-12
|
C22H20N4 |
340.421 | |
IMD 0354
|
978-62-1 |
N-[3,5-双(三氟甲基)苯基]-5-氯-2-羟基苯甲酰胺
|
IMD 0354;IMD-0354;IKK-2 INHIBITOR V;IMD 0354;IMD0354;N-[3,5-双(三氟甲基)苯基]-5-氯-2-羟基苯甲酰胺;IMD-0354,一种合成的选择性NF-KB 抑制剂
|
C15H8NO2F6Cl |
383.67292 |